Omnicell (OMCL)
(Delayed Data from NSDQ)
$29.72 USD
-0.22 (-0.73%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $29.78 +0.06 (0.20%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Brokerage Reports
Omnicell, Inc. [OMCL]
Reports for Purchase
Showing records 301 - 320 ( 328 total )
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Univ. of Chicago Announcement Lends Comfort to Estimates; Reiterate BUY
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Modest Q2 Beat: Raising Target to $19 While Reiterating BUY
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Healthcare IT & Services -Life at the Top: Revisiting Health IT Valuations
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Management Meetings Support Investment Thesis; Reiterate BUY
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Quarter, Guidance In-line: Reiterate BUY & Raise Target to $17
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Strong Results, Guidance Reiterated: Maintain Buy and $16 Price Target.
Provider: AURIGA USA
Analyst: MANNHEIMER G
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Company: Omnicell, Inc.
Industry: Medical Info Systems
Management Meetings, Checks Confirm Not Losing Its Step: Reiterate Buy
Provider: AURIGA USA
Analyst: MANNHEIMER G